The purpose of this study is to find out the clinical and pathological response rates of pre-operative concurrent chemoradiotherapy (CCRT) with twice weekly paclitaxel and cisplatin in patient with locally advanced esophageal cancer.
CCRT with twice weekly paclitaxel and cisplatin in patient with locally advanced esophageal cancer.